Tag: clinical trial registries

Open Access Policies of Journals and Sponsors in Clinical Trials

Posted on digi By digi

Open Access Policies of Journals and Sponsors in Clinical Trials How Journals and Sponsors Shape Open Access in Clinical Trial Publication Introduction: Why Open Access is Now Non-Negotiable Open access (OA) has moved from being an academic preference to a clinical trial mandate. Regulatory agencies, funding bodies, and public advocacy groups are demanding increased transparency…

Read More “Open Access Policies of Journals and Sponsors in Clinical Trials” »

Clinical Trial Transparency and Ethics, Open Access Data Sharing

Best Practices for Writing Summary Results Tables

Posted on digi By digi

Best Practices for Writing Summary Results Tables Crafting Effective Summary Results Tables for Clinical Trial Registries Importance of Summary Tables in Results Disclosure Summary results tables are the foundation of data transparency on public clinical trial registries. These tables condense the trial’s key findings into structured, readable, and regulatory-compliant formats. Agencies like the FDA, EMA,…

Read More “Best Practices for Writing Summary Results Tables” »

Clinical Trial Registries and Result Disclosure, Results Posting Requirements

Transparency in Reporting Rare Disease Trial Outcomes: Ethical and Regulatory Imperatives

Posted on digi By digi

Transparency in Reporting Rare Disease Trial Outcomes: Ethical and Regulatory Imperatives Ensuring Transparency in Rare Disease Clinical Trial Reporting Why Transparency Matters in Rare Disease Trials In rare disease research, every datapoint matters. Due to the small patient populations, heterogeneous outcomes, and complex endpoints, publishing accurate and timely trial results becomes not just a regulatory…

Read More “Transparency in Reporting Rare Disease Trial Outcomes: Ethical and Regulatory Imperatives” »

Ethics & Patient Engagement, Rare and Orphan Disease Trials